General Genetics Corporation

Based in the US, General Genetics Corporation specializes in providing innovative genetic and biotechnology solutions, enhancing operational efficiency for various sectors including healthcare and logistics through advanced software platforms. General Genetics Corporation is focused on genetic and biotechnology solutions. Founded in 2013 and headquartered in Las Cruces, US, the company has engaged in 2 deals, with the latest being on September 9, 2021, when Genetic Technologies Limited acquired its international division from BelHealth Investment Partners, marking a strategic shift in ownership and focus. The company's core offerings revolve around innovative technology solutions that address specific challenges faced by their clients across various industries.

Their flagship product is a proprietary software platform designed to streamline operational processes, enhancing efficiency and productivity for end users. This platform caters to businesses in sectors like finance, logistics, and healthcare, facilitating seamless data management and real-time analytics. The product suite includes customizable modules that allow for a tailored experience, maximizing value for individual clients. General Genetics Corporation actively markets its solutions in North America and Europe, targeting mid-sized enterprises aiming to optimize operations through advanced technology.

The company's revenue model is primarily based on a subscription service for its flagship software platform, which operates on a tiered pricing structure to accommodate varying client needs. Clients typically engage in annual contracts providing access to the software along with ongoing support and updates. Additionally, General Genetics Corporation offers partnership opportunities with retailers and wholesalers, enhancing distribution channels for their solutions. Revenue is generated from both direct-to-consumer transactions and B2B engagements, ensuring flexibility in how clients access and utilize the products.

The pricing plans are structured for scalability, allowing clients to choose packages that align with their operational requirements and budget constraints. In September 2021, the company underwent a significant transition when its international division was acquired by Genetic Technologies Limited, with financial terms undisclosed. This strategic move positions General Genetics Corporation for future development, focusing on enhancing its product offerings and expanding its market presence. Future plans may include the development of new software tools and expansion into Asian and European markets by 2023, leveraging the recent acquisition to broaden its operational capabilities and distribution networks.